Skip to main content

Table 2 Summary of patient demographic and healthcare utilisation characteristics in differing HCV health-states

From: Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study

Characteristic Mild Mod. Comp. Cirrhosis Decomp. Cirrhosis HCC Transplant Year 1 Transplant > Year 1 SVR
N 40 29 24 13 27 33 31 28
Mean Age (SD) 38 (8) 48 (10) 45 (9) 46 (7) 55 (11) 47 (9) 54 (9) 34 (10)
Male n (%) 25 (61) 16 (55) 25 (89) 12 (98) 23 (85) 22 (67) 19 (66) 22 (79)
Patient years of follow-up 214 137 102 23 39 33 187 84
Annual mean number of medical reviews (95%CI) 1.3 (1.1, 1.5) 1.4 (1.2,1.7) 1.8 (1.5, 2.1) 4.6 (4.2, 4.9) 5.2 (4.6, 5.8) 11.9 (10.4, 13.2) 4.3 (4.0, 4.6) 0.36 (0.22, 0.5)
Annual mean number of nursing reviews (95 % CI) 0.5 (0.3, 0.7) 0.9 (0.6, 1.2) 1.8 (0.9, 2.6) 5.1 (4.3,5.9) 3.6 (3.1, 4.1) n/a n/a 0.1 (0.0, 0.04)
Annual mean number of inpatient episodes (95%CI) n/a n/a 0.2 (0.06, 0.4) 2.5 (2.1, 3.0) 2.1 (1.8, 2.3) 1.1 (0.6, 1.6) 0.24 (0.1, 0.38) n/a
  1. Mod moderate, Comp. cirrhosis Compensated cirrhosis, Decomp. Cirrhosis decompensated cirrhosis, HCC hepatocellular carcinoma, Transplant Year 1 First 12 months of liver transplantation, Transplantation > Year 1 Transplantation After First 12 months, SVR Sustained Viral Response